Perceptronix Medical Inc. announces partnership with LED Dental Inc. for commercialization of laboratory services in Canada
Perceptronix Medical Inc ("PMI") is pleased to announce that it has entered into a partnership with LED Dental Inc. ("LED") for commercializing the Second Step laboratory services to all VELscope users and other dental professionals in Canada.
- (1888PressRelease) March 10, 2012 - VANCOUVER, CANADA - "We view this partnership as a significant strategic step to delivering comprehensive pathology laboratory service to the dental community. The feasibility study showed tremendous market response for services like ours, and we look forward to the exciting work ahead," says Dr. Bojana Turic, President and CEO of PMI.
PMI has developed an anatomic pathology laboratory service (qualitative and quantitative as well as biopsy service) uniquely specializing in early cancer detection using the Company's proprietary quantitative cytology technology. The Company's oral cancer detection test, OralAdvance™, is based on measuring large-scale DNA abnormalities in brush cytology samples with computer assistance, an analysis that can indicate precancerous or cancerous changes in cell nuclei.
The Company will incorporate OralAdvance™ analysis in the Second Step initiative of LED. The transition time for all OralAdvance™ users into Second Step service is expected to take less then a week.
"Early detection and diagnoses is extremely important in treating oral cancer," said Peter Whitehead, CEO of LED Dental and its parent company, LED Medical Diagnostics Inc. (TSX VENTURE:LMD). "The partnership between Second Step and LED Dental allows dental professionals to enhance the oral cancer detection and diagnoses services they provide to their patients, and ensure those services are delivered in a timely manner."
LED Dental and PMI are utilizing technology originally invented and developed at the BC Cancer Agency in Vancouver to provide early cancer detection for all Canadians.
About Perceptronix Medical Inc.
Perceptronix Medical Inc. Laboratories ("PMI Labs") provide anatomic pathology and cancer diagnostics services to medical and dental practices and facilities in support of earlier diagnoses for better patient outcomes.
In addition to our full laboratory service we uniquely specialize in early cancer detection using quantitative cytology approach, measuring a large-scale DNA abnormality with computer assistance, an analysis that can indicate precancerous or cancerous changes in nuclei.
About LED Medical Diagnostics Inc.
Founded in 2003, LED Medical Diagnostics Inc., (TSV VENTURE: LMD) is a fast-growing public company offering effective early-stage oral cancer detection technologies in 23 countries worldwide. The company makes the VELscope Vx, the most powerful tool for detecting early stage oral cancer approved by the FDA, Health Canada and European regulators. The company is headquartered in Burnaby British Columbia, Canada. For more information please call +1 (604) 434-4614, or visit our webiste.
For more information please contact:
Alexei Doudkine, Ph.D.
Director, Business Development
Tel: 604.629.8787 |
Toll Free: 1.888.629.8785, ext.231